Emison

艾米森

Emison

Biotech/Healthcare

Aimisen has independently developed a new painless, non-invasive, and highly sensitive tumor detection technology. It has launched the Aike'an™ series of early non-invasive screening products for prevalent cancers, including lung, colorectal, cervical, liver, gastric, esophageal, and urinary system…

Latest round: Series C (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-04-01